Retirement Guys Formula LLC Has $769,000 Stake in Colgate-Palmolive (NYSE:CL)

Retirement Guys Formula LLC lifted its position in Colgate-Palmolive (NYSE:CL) by 15.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,463 shares of the company’s stock after purchasing an additional 1,125 shares during the quarter. Retirement Guys Formula LLC’s holdings in Colgate-Palmolive were worth $769,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Koshinski Asset Management Inc. grew its position in Colgate-Palmolive by 15.4% in the third quarter. Koshinski Asset Management Inc. now owns 7,734 shares of the company’s stock valued at $803,000 after acquiring an additional 1,034 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH grew its position in Colgate-Palmolive by 54.7% in the third quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 24,075 shares of the company’s stock valued at $2,499,000 after acquiring an additional 8,510 shares during the period. Creative Planning grew its position in Colgate-Palmolive by 2.0% in the third quarter. Creative Planning now owns 218,018 shares of the company’s stock valued at $22,632,000 after acquiring an additional 4,372 shares during the period. Occidental Asset Management LLC grew its position in Colgate-Palmolive by 25.1% in the third quarter. Occidental Asset Management LLC now owns 3,579 shares of the company’s stock valued at $372,000 after acquiring an additional 719 shares during the period. Finally, NBC Securities Inc. grew its position in Colgate-Palmolive by 49.3% in the third quarter. NBC Securities Inc. now owns 5,463 shares of the company’s stock valued at $567,000 after acquiring an additional 1,804 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.6 %

NYSE:CL opened at $87.35 on Wednesday. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30. The business’s 50-day moving average price is $90.14 and its two-hundred day moving average price is $96.69. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $71.37 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the business earned $0.87 EPS. On average, equities analysts expect that Colgate-Palmolive will post 3.73 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.29%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.

Analyst Ratings Changes

A number of analysts have weighed in on the company. TD Cowen lowered their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. UBS Group decreased their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.